JCM Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
JCM.02198-07v1
46/6/2119    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Google Scholar
Right arrow Articles by Tu, E. T.-V.
Right arrow Articles by White, P. A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tu, E. T.-V.
Right arrow Articles by White, P. A.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, June 2008, p. 2119-2121, Vol. 46, No. 6
0095-1137/08/$08.00+0     doi:10.1128/JCM.02198-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Norovirus Excretion in an Aged-Care Setting{triangledown}

Elise T.-V. Tu,1,3 Rowena A. Bull,1,3 Mi-Jurng Kim,1 Christopher J. McIver,1,2,3 Leon Heron,4 William D. Rawlinson,1,2,3 and Peter A. White1*

School of Biotechnology and Biomolecular Sciences, Faculty of Science,1 School of Medical Sciences, Faculty of Medicine, The University of New South Wales, UNSW, Sydney 2052, Australia,2 Virology Division, SESIAHS, Department of Microbiology, Prince of Wales Hospital, Sydney 2031, Australia,3 National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, Research Building, The Children's Hospital at Westmead, Westmead 2145, Australia4

Received 13 November 2007/ Returned for modification 11 January 2008/ Accepted 9 April 2008

Norovirus genogroup II excretion during an outbreak of gastroenteritis was investigated in an aged-care facility. Viral shedding peaked in the acute stage of illness and continued for an average of 28.7 days. The viral decay rate was 0.76 per day, which corresponds to a viral half-life of 2.5 days.

* Corresponding author. Mailing address: School of Biotechnology and Biomolecular Sciences, Faculty of Science, University of New South Wales, Sydney 2052, Australia. Phone: 61 9385 3780. Fax: 61 9385 1483. E-mail: p.white{at}unsw.edu.au

{triangledown} Published ahead of print on 16 April 2008.

Journal of Clinical Microbiology, June 2008, p. 2119-2121, Vol. 46, No. 6
0095-1137/08/$08.00+0     doi:10.1128/JCM.02198-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.





Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2008 by the American Society for Microbiology. All rights reserved.